Mid Penn Bank Donates $100,000 to Basser Center for BRCA at Penn Medicine
For the third year, Mid Penn Bank raised money for the Basser Center for BRCA at Penn Medicine through its annual Celebrity Golf Classic. This year’s event, which took place in July, resulted in a $100,000 donation to the Basser Center.
Men Need to Worry About BRCA Mutations Too
The Basser Center for BRCA at Penn Medicine recently launched the Men & BRCA Program to propel research and education focusing on men with BRCA mutations.
One-Stop Shops for Patients with BRCA Mutations
In 2012, the Basser Center was established as the first comprehensive center for the research, treatment, and prevention of BRCA1 and BRCA2-related cancers. Now, other academic institutions have followed suit, creating their own BRCA programs.
WSJ: Researchers At Health Institutions Like Penn Medicine Are Testing Vaccines to Prevent Cancer
Researchers across the country are making progress toward vaccines that train healthy people’s immune systems to eliminate signs of cancer before it develops. Healthy BRCA mutation carriers are participating in a clinical trial.
BRCA Testing in Male Patients Slipping Through the Net
A review published by Kara Maxwell, MD, PhD, highlighted that BRCA genetic testing rates among men remain striking low, despite a heightened risk of breast, pancreatic, and prostate cancers in males with BRCA mutations.
New Loungewear Collection Raises Money for Breast Cancer
“This initiative will support our work dedicated to helping those affected by BRCA gene mutations through treatment, awareness, prevention, and research,” said Susan Domchek, MD, executive director of the Basser Center.
Jill Martin's Winning Game Plan: Turning Challenges into Opportunities
TODAY Show contributor and breast cancer survivor Jill Martin launched a new clothing line to raise awareness of breast cancer and genetic testing, with proceeds going to the Basser Center.
Can We Prevent Cancer With a Shot?
Healthy volunteers who carry BRCA gene mutations are participating in a cancer vaccine clinical trial. If the study is successful, the work could eventually extend to more cancers or other risk factors, noted ACC director Dr. Vonderheide.
The Biology of ‘Precancer’: Stopping Cancer Before It Starts
As Dr. Susan Domchek leads a clinical trial for a cancer interception vaccine, the team seeks to understand “precancer”—the critical period after cells have started to grow abnormally but before they’ve developed into cancer.
BRCA Testing in Male Patients Slipping Through the Net
Kara Maxwell, MD, PhD, highlighted that BRCA genetic testing rates among men remain striking low, despite a heightened risk of breast, pancreatic, and prostate cancers in males with BRCA mutations.